Ekso Bionics Holdings, Inc. (EKSO)Healthcare | Medical Instruments & Supplies | San Rafael, United States | NasdaqCM
10.81 USD
+0.45
(4.344%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 11.00 +0.19 (1.758%) ⇧ (April 17, 2026, 4:45 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 18, 2026, 10:20 p.m. EDT
Despite a recent 29% price bounce and a bullish short-term momentum prediction (8.8%), EKSO is structurally dying: it is acquiring a cloud unit (ChronoScale), effectively doing a merger itself rather than focusing on its exoskeleton core, while reporting a -38% revenue decline, negative free cash flow, and a absence of dividends. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.094964 |
| AutoETS | 0.200420 |
| AutoARIMA | 0.205135 |
| MSTL | 0.233135 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 45% |
| H-stat | 5.06 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.083 |
| Excess Kurtosis | 1.27 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 51.446 |
| Revenue per Share | 5.276 |
| Market Cap | 38,520,152 |
| Forward P/E | -56.89 |
| Beta | 0.78 |
| Profit Margins | -91.37% |
| Website | https://www.eksobionics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.7663399 |
| Address1 | 101 Glacier Point |
| Address2 | Suite A |
| All Time High | 12,946.5 |
| All Time Low | 2.73 |
| Ask | 10.98 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 73,220 |
| Average Daily Volume3 Month | 121,675 |
| Average Volume | 121,675 |
| Average Volume10Days | 73,220 |
| Beta | 0.776 |
| Bid | 10.56 |
| Bid Size | 1 |
| Book Value | 2.536 |
| City | San Rafael |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 10.81 |
| Current Ratio | 1.627 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 11.195 |
| Day Low | 10.22 |
| Debt To Equity | 51.446 |
| Display Name | Ekso Bionics |
| Dividend Date | 1,585,094,400 |
| Earnings Call Timestamp End | 1,753,734,600 |
| Earnings Call Timestamp Start | 1,753,734,600 |
| Earnings Timestamp End | 1,777,924,800 |
| Earnings Timestamp Start | 1,777,924,800 |
| Ebitda | -11,003,000 |
| Ebitda Margins | -0.85968 |
| Enterprise To Ebitda | -3.817 |
| Enterprise To Revenue | 3.281 |
| Enterprise Value | 41,995,148 |
| Eps Forward | -0.19 |
| Eps Trailing Twelve Months | -4.91 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 10.4673 |
| Fifty Day Average Change | 0.3427 |
| Fifty Day Average Change Percent | 0.032740057 |
| Fifty Two Week Change Percent | 76.63399 |
| Fifty Two Week High | 13.5 |
| Fifty Two Week High Change | -2.6899996 |
| Fifty Two Week High Change Percent | -0.19925922 |
| Fifty Two Week Low | 2.73 |
| Fifty Two Week Low Change | 8.08 |
| Fifty Two Week Low Change Percent | 2.959707 |
| Fifty Two Week Range | 2.73 - 13.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,389,969,000,000 |
| Float Shares | 2,237,625 |
| Forward Eps | -0.19 |
| Forward P E | -56.89474 |
| Free Cashflow | -4,496,125 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 50 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.53481 |
| Gross Profits | 6,845,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.24538 |
| Held Percent Institutions | 0.26743 |
| Implied Shares Outstanding | 3,563,381 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,748,822,400 |
| Last Split Factor | 1:15 |
| Long Business Summary | Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California. |
| Long Name | Ekso Bionics Holdings, Inc. |
| Market | us_market |
| Market Cap | 38,520,152 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_206802444 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -11,921,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 38,377,613 |
| Number Of Analyst Opinions | 1 |
| Open | 10.49 |
| Operating Cashflow | -11,801,000 |
| Operating Margins | -1.19713 |
| Payout Ratio | 0.0 |
| Phone | 510 984 1761 |
| Post Market Change | 0.18999958 |
| Post Market Change Percent | 1.7576278 |
| Post Market Price | 11.0 |
| Post Market Time | 1,776,458,750 |
| Previous Close | 10.36 |
| Price Hint | 2 |
| Price To Book | 4.2626185 |
| Price To Sales Trailing12 Months | 3.009622 |
| Profit Margins | -0.91374 |
| Quick Ratio | 0.982 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.450001 |
| Regular Market Change Percent | 4.34364 |
| Regular Market Day High | 11.195 |
| Regular Market Day Low | 10.22 |
| Regular Market Day Range | 10.22 - 11.195 |
| Regular Market Open | 10.49 |
| Regular Market Previous Close | 10.36 |
| Regular Market Price | 10.81 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 56,638 |
| Return On Assets | -0.33616 |
| Return On Equity | -1.07619 |
| Revenue Growth | -0.383 |
| Revenue Per Share | 5.276 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 3,563,381 |
| Shares Percent Shares Out | 0.0553 |
| Shares Short | 196,901 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 247,981 |
| Short Name | Ekso Bionics Holdings, Inc. |
| Short Percent Of Float | 0.0668 |
| Short Ratio | 2.62 |
| Source Interval | 15 |
| State | CA |
| Symbol | EKSO |
| Target High Price | 9.5 |
| Target Low Price | 9.5 |
| Target Mean Price | 9.5 |
| Target Median Price | 9.5 |
| Total Cash | 1,169,000 |
| Total Cash Per Share | 0.328 |
| Total Debt | 4,644,000 |
| Total Revenue | 12,799,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.91 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.39345 |
| Two Hundred Day Average Change | 4.4165506 |
| Two Hundred Day Average Change Percent | 0.69079304 |
| Type Disp | Equity |
| Volume | 56,638 |
| Website | https://www.eksobionics.com |
| Zip | 94,901 |